BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The BioCalendar - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The BioCalendar
X-ORIGINAL-URL:https://thebiocalendar.com
X-WR-CALDESC:Events for The BioCalendar
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20240310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20241103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20251217T110000
DTEND;TZID=America/Los_Angeles:20251217T120000
DTSTAMP:20260404T065140
CREATED:20251124T130033Z
LAST-MODIFIED:20251124T130033Z
UID:9570-1765969200-1765972800@thebiocalendar.com
SUMMARY:Advancing targeted in vivo LNPs: Five practical considerations to move from concept to clinic
DESCRIPTION:As genetic medicine advances toward targeted in vivo delivery\, developers face new challenges in translating promising concepts into clinical reality. From payload design to conjugation chemistry and analytics\, each decision shapes manufacturability\, scalability\, and regulatory success. \nIn this webinar\, experts from Cytiva will share five practical considerations for teams advancing targeted in vivo LNP programs — covering formulation selection\, conjugation and targeting strategies\, bioanalytical readiness\, process complexity\, and the approaches to enable clinical development. \nDrawing on experience from ARPA-H-funded initiatives and real-world collaborations\, the discussion will explore proven strategies that help innovators anticipate and overcome common development hurdles. \nAttendees will walk away with a framework for designing in vivo programs that are technically robust\, scalable\, and ready for clinical advancement — helping teams accelerate the journey from concept to clinic.
URL:https://thebiocalendar.com/event/advancing-targeted-in-vivo-lnps-five-practical-considerations-to-move-from-concept-to-clinic/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2025/11/12-17-25-Cytiva-eBlast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20251216T110000
DTEND;TZID=America/Los_Angeles:20251216T120000
DTSTAMP:20260404T065140
CREATED:20251201T200251Z
LAST-MODIFIED:20251201T200251Z
UID:9609-1765882800-1765886400@thebiocalendar.com
SUMMARY:Overcoming Regulatory Hurdles in AAV Production
DESCRIPTION:As cell and gene therapy (CGT) advances\, regulatory expectations around product quality and manufacturing rigor continue to rise—especially in viral vector production. One emerging challenge is the need to demonstrate clearance of residual reagents used during upstream processing\, a requirement increasingly emphasized by regulatory agencies like the FDA. \nIn this webinar\, Miguel Dominguez and Lloyd Achirem from Mirus Bio (part of MilliporeSigma) will explore how AAV manufacturers can address this pain point through strategic partnerships and innovations. We’ll introduce a newly developed residual reagent assay tailored to Mirus Bio solutions that helps streamline regulatory submissions and supports quality assurance in viral vector workflows. \nJoin us to learn how the team can support your compliance strategy and hear directly from the experts driving these innovations in AAV production.
URL:https://thebiocalendar.com/event/overcoming-regulatory-hurdles-in-aav-production/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2025/12/1764077467882.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251215T110000
DTEND;TZID=America/New_York:20251215T120000
DTSTAMP:20260404T065140
CREATED:20251125T172045Z
LAST-MODIFIED:20251125T172135Z
UID:9597-1765796400-1765800000@thebiocalendar.com
SUMMARY:Bridging the Gap between Product Readiness and Equipment Availability
DESCRIPTION:Launch-ready & peak-proof: Discover how to bridge packaging gaps and act as a reliable backup during demand surges. You’ll learn how manual precision at an industrial scale ensures seamless transitions to automated packaging\, and why this approach is a game-changer for accelerating product launches.
URL:https://thebiocalendar.com/event/bridging-the-gap-between-product-readiness-and-equipment-availability/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2025/11/12-15-25-Koerber-LinkedIn-1280x720-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20251211T150000
DTEND;TZID=America/Los_Angeles:20251211T183000
DTSTAMP:20260404T065140
CREATED:20251109T111619Z
LAST-MODIFIED:20251109T111619Z
UID:9490-1765465200-1765477800@thebiocalendar.com
SUMMARY:Meet the Leaders & Holiday Mixer Hosted by the LSPA Board of Directors
DESCRIPTION:Meet the Leaders\, is a complimentary session featuring leaders from Merck and Sanofi as they discuss vaccine policy and advocacy\, navigating federal priorities and advocacy initiatives. Head to our office after the program to enjoy our annual Holiday Mixer! Network with LSPA Board members\, enjoy live music and cocktails\, and celebrate the end of the year with the life sciences community. \nThis event precedes the LSPA Holiday Mixer. The Holiday Mixer will begin at 4:30 PM. \n\nDate: Thursday\, December 11\, 2025\nTime: 3:00 PM – 4:30 PM\nLocation: LSPA Auditorium | 411 Swedeland Road\, King of Prussia\, PA 19406\nSpeakers:\n\nArthur Hirt\, Senior Vice President\, U.S. Vaccines & Infectious Diseases Business Unit\, Merck\nThomas Grenier\, Head of Vaccines\, North America\, Sanofi\nModerator: Brian Doerner\, Partner\, Ballard Spahr\n\n\n\n* Meet The Leaders event is included with your Holiday Mixer registration; however\, please indicate when registering if you will be attending the session.
URL:https://thebiocalendar.com/event/meet-the-leaders-holiday-mixer-hosted-by-the-lspa-board-of-directors/
LOCATION:King of Prussia\, PA\, King of Prussia\, PA\, 19406\, United States
CATEGORIES:Forum,Social
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20251211T080000
DTEND;TZID=America/Los_Angeles:20251211T110000
DTSTAMP:20260404T065140
CREATED:20251125T142058Z
LAST-MODIFIED:20251125T142058Z
UID:9578-1765440000-1765450800@thebiocalendar.com
SUMMARY:2025 New York Life Sciences & Biotech Summit
DESCRIPTION:What You’ll Learn: \n\nWhich macro policy shifts from NIH indirect caps to ESG financing mandates could reshape New York’s ecosystem in the years ahead?\nWith NYC’s lab vacancy rate being on of the highest in country the highest in the country (~42% in 2025)\, how developers are adapting to a strong tenant market?\nWhich life sciences developments are best in class in New York and what is driving tenants to these buildings?\nWhich infrastructure policies are driving development activity\, project approval and fostering growth for the region’s tenants?\nHow venture capital flows\, public incentives\, and NIH policy changes are influencing life sciences funding heading into 2026?\nWhy are plug and play spaces are outperforming spec in today’s environment?\nHow Long Island’s push into cell and gene therapy manufacturing reshapes the regional map?\nWhich markets can serve as a blueprints or reference points for the future of the city’s life science developments? \n\nHow you’ll do more business: Enhance your business by understanding how the New York life sciences community is growing to compete with other top biotech hubs across the country. Gain a better understanding for what tenants are looking for as they grow and expand. Additionally\, what design and development strategies are top executives implementing in these top clusters.   \nWho attends: Investors\, owners\, developers\, lenders\, biotech tenants\, brokers\, public sector companies\, architects\, contractors\, engineers and property managers.  \nWhy should you attend: Bisnow events bring together the biggest power players in the industry to identify opportunities\, build your network\, and expand your business. With the largest audience of commercial real estate professionals in the world\, no one knows how to help your business more than us.
URL:https://thebiocalendar.com/event/2025-new-york-life-sciences-biotech-summit/
LOCATION:New York\, New York\, NY\, United States
CATEGORIES:Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251211
DTEND;VALUE=DATE:20251212
DTSTAMP:20260404T065140
CREATED:20250718T160248Z
LAST-MODIFIED:20250718T160250Z
UID:8496-1765411200-1765497599@thebiocalendar.com
SUMMARY:Advancing Drug Development Forum
DESCRIPTION:This forum is designed to allow free-flowing dialogue and plenty of time has been woven throughout the day to assure interactive quality networking.  \nThe forum strives to attract and stimulate dialogue with key opinion leaders in biotech and pharma\, executive leadership\, senior directors\, consultants\, and a close network of CROs and CDMOs to further explore together novel solutions\, promising technology breakthroughs and hearing how the entrepreneurial industry leaders are introducing and incorporating novel approaches in small molecule drug development\, changing timelines and ROIs. Hear for yourself\, how you can speed up your timelines and improve your product quality.  \nThe program will include two keynote presentations\, the first presentation of the day is an interview with a biotech CEO that has seen their company change dramatically within the last year. The second keynote is from an Academic that is bringing future innovations to the industry. At the end of the day a fireside chat is moderated with two inspiring individuals from our industry. 
URL:https://thebiocalendar.com/event/advancing-drug-development-forum/
LOCATION:Cambridge\, MA\, Cambridge\, MA\, 02139\, United States
CATEGORIES:Forum
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20251210T110000
DTEND;TZID=America/Los_Angeles:20251210T121500
DTSTAMP:20260404T065140
CREATED:20251121T115231Z
LAST-MODIFIED:20251121T115231Z
UID:9560-1765364400-1765368900@thebiocalendar.com
SUMMARY:The Power of Presenting at Biotech Showcase
DESCRIPTION:The Power of Presenting at Biotech Showcase – Unlocking Investor Interest and Strategic Partnerships \nIn this dynamic and insightful panel\, we bring together a diverse group of industry leaders to explore the art and science of successful presentations at Biotech Showcase. As one of the largest and most influential healthcare investor conferences\, Biotech Showcase takes place during “Healthcare Week” in San Francisco and offers unparalleled opportunities for biotech\, TechBio\, and seed companies to gain visibility\, attract investment\, and forge strategic partnerships. This session is designed to equip presenting companies with the tools and strategies needed to maximize their impact and stand out in a competitive landscape.
URL:https://thebiocalendar.com/event/the-power-of-presenting-at-biotech-showcase/
LOCATION:Online
CATEGORIES:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251210
DTEND;VALUE=DATE:20251211
DTSTAMP:20260404T065140
CREATED:20250711T171659Z
LAST-MODIFIED:20250711T171659Z
UID:8449-1765324800-1765411199@thebiocalendar.com
SUMMARY:CLS Innovation Showcase
DESCRIPTION:Held biannually\, the CLS Innovation Showcase brings approximately 300+ life sciences stakeholders\, including biopharma representatives\, investors\, key advisors\, and expert service providers\, together to foster connections and vital partnering conversations while spotlighting California’s robust innovation. The full-day event typically features a keynote presentation\, panel discussions\, pitches by our FAST cohort to a panel of early-stage investors and the opportunity to set up one-on-one partnering meetings. The afternoon will conclude with a networking reception and solutions corridor\, featuring CLS cost savings partners.
URL:https://thebiocalendar.com/event/cls-innovation-showcase/
LOCATION:South San Francisco\, CA\, CA\, 94080\, United States
CATEGORIES:Forum,Networking,Partnering
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20251209T163000
DTEND;TZID=America/Los_Angeles:20251209T190000
DTSTAMP:20260404T065140
CREATED:20251111T185729Z
LAST-MODIFIED:20251111T185729Z
UID:9506-1765297800-1765306800@thebiocalendar.com
SUMMARY:BVS' Holiday Biotech Community Event at Green Acre Campus Point\, San Diego
DESCRIPTION:We are very excited to invite you our BVS Holiday Biotech Community Event – an evening of celebration\, networking\, and festive cheer! \nMark your calendars for a great opportunity to connect with industry leaders\, explore innovative products\, and mingle with fellow professionals in the biotech community. \nThis special event is designed exclusively for all the life science researchers and entrepreneurs in San Diego. \n✨ What to Expect: \n    Vendor Exhibit: Discover a diverse range of exhibitors showcasing cutting-edge technology and services in the biotech space.\n    Networking Opportunities: Engage with fellow industry experts\, forge new connections\, and exchange ideas that could shape the future of biotech.\n    Delicious Holiday Appetizers & Drinks: Enjoy a selection of delightful treats as you mingle. \nOur biotech community events always attract 200+ people. We are giving out holiday swag for everyone to dress up and encouraging creative holiday costumes. \nAdmission Details:\nFREE for life science job-related employees (including researchers\, scientists\, purchasing\, clinical\, manufacturing\, non-sales/bus dev positions etc.) from life science companies and research institutes.\n$200 fee for product and service providers who sell to the life science community (e.g. BVS suppliers\, business development/sales\, marketing\, lawyers\, consultants)\, which includes access to the event but does not include an exhibitor table. Exhibitor tables can be purchased separately. \nFor exhibitor tables\, please visit our website and register at: https://bvsconnection.com/events \nDon’t miss out on this fantastic opportunity to celebrate the holiday season and strengthen our biotech community. \nWe look forward to seeing you there!
URL:https://thebiocalendar.com/event/bvs-holiday-biotech-community-event-at-green-acre-campus-point-san-diego-2/
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2025/11/BVS-Event-Flyer-12-09-25.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20251209T130000
DTEND;TZID=America/Los_Angeles:20251209T140000
DTSTAMP:20260404T065140
CREATED:20251106T150246Z
LAST-MODIFIED:20251106T150246Z
UID:9448-1765285200-1765288800@thebiocalendar.com
SUMMARY:Seal the Deal: Mastering Vent Integration in Medical Devices
DESCRIPTION:Join W.L. Gore & Associates Application Specialist David Kunzig to explore the critical role of venting and microfiltration in life science applications\, from infusion\, drug delivery\, surgical suction\, negative pressure wound therapy\, diagnostics\, hemodialysis\, eye surgery\, urology\, and ostomy. Discover how vent orientation and placement can make or break system performance\, using relatable analogies and real-world visuals. Dive into Gore’s experience with welding technologies\, design considerations\, and troubleshooting strategies that lead to more reliable integration across diverse polymers. \nThrough a detailed case study\, we’ll share how even stable processes can encounter unexpected challenges\, and how practical\, hands-on investigation can uncover the root cause. Whether you’re designing devices or refining manufacturing processes\, this webinar delivers actionable insights to elevate your engineering outcomes.
URL:https://thebiocalendar.com/event/seal-the-deal-mastering-vent-integration-in-medical-devices/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2025/11/12-09-25-WL-Gore-eBlast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20251209T110000
DTEND;TZID=America/Los_Angeles:20251209T120000
DTSTAMP:20260404T065140
CREATED:20251107T125340Z
LAST-MODIFIED:20251107T125340Z
UID:9464-1765278000-1765281600@thebiocalendar.com
SUMMARY:From Hesitation to Confidence: Should Sponsors Provide Source Document Templates to Sites? Let's Debate
DESCRIPTION:This webinar will explore multiple perspectives on whether study sponsors should provide standardized\, study-specific eSource templates to investigative sites. Attendees will examine practical implications\, legal and regulatory considerations\, and the distinct advantages and challenges from both sponsor and site viewpoints. Through structured debate and expert insights\, participants will gain clarity on this complex operational and compliance question and understand why there is some industry division.
URL:https://thebiocalendar.com/event/from-hesitation-to-confidence-should-sponsors-provide-source-document-templates-to-sites-lets-debate/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2025/11/12-09-25-Crio-eblast-700x200-copy.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20251209T080000
DTEND;TZID=UTC:20251211T170000
DTSTAMP:20260404T065140
CREATED:20250822T034313Z
LAST-MODIFIED:20250825T115324Z
UID:8958-1765267200-1765472400@thebiocalendar.com
SUMMARY:Trade and Channel Strategies
DESCRIPTION:Driven by market dynamics and led by champions of channel strategy\, Trade and Channel Strategies celebrates its 20th year as the industry’s premier event for trade\, channel\, market access\, account strategy and brand professionals in the pharmaceutical and biotech arena. Trade 2025 marks two decades of excellence\, diving into the top trends for innovative distribution\, integrated pharmacy models and the future of trade. As the must-attend event for essential industry updates and benchmarks\, this milestone year promises to look at just how far the industry has come and provide contemporary solutions to master the complexities of pharmacy and distribution models\, accelerate market access and foster robust networking opportunities to expand your network.\n\nUse promo 25B4B10 to save 10%.
URL:https://thebiocalendar.com/event/trade-and-channel-strategies-3/
LOCATION:Philadelphia\, Philadelphia\, PA\, United States
CATEGORIES:Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20251209T080000
DTEND;TZID=America/Los_Angeles:20251209T120000
DTSTAMP:20260404T065140
CREATED:20251125T142252Z
LAST-MODIFIED:20251125T142252Z
UID:9579-1765267200-1765281600@thebiocalendar.com
SUMMARY:Mid-Atlantic Life Sciences & Biotech Summit in Maryland
DESCRIPTION:After an explosive pandemic-era expansion\, the Mid-Atlantic life sciences market is undergoing a reset. According to Cushman & Wakefield\, availability in Suburban Maryland alone has climbed to a record 20.2%\, with 14% vacancy and more space expected to hit the market as venture funding slows\, federal budget cuts reduce new tenant formation\, and several firms face bankruptcy or capital shortfalls. \n  \nThese conditions are pushing landlords to rethink their strategies. Owners of large life science blocks are actively pursuing medical office conversions\, alternative uses\, and flexible buildouts to widen the tenant pool and stabilize occupancy. The market’s transition is reshaping underwriting assumptions and forcing a sharper focus on adaptable\, future-proof space. \n  \nFor tenants\, this is a highly favorable moment: rental rates remain steady in the low-to-mid $40s psf\, while landlords are offering shorter terms\, richer concessions\, and more negotiable deal structures. Early-stage companies\, in particular\, are gravitating toward spec suites and second-generation lab space that minimize upfront capital. \n  \nFor market participants\, success will hinge on flexibility\, creative repositioning\, and understanding a tenant-driven landscape in flux. Join our panel of experts\, from venture capitalists to developers\, occupiers and associations\, to understand how to position yourself best for success in today’s evolving and rapidly-changing market. \nWhat You’ll Learn:  \n\nHow are changes in tenant demand for life sciences spaces influencing the design and development of lab and office environments\, particularly in the Mid-Atlantic\, and what trends are emerging to accommodate evolving needs in functionality\, flexibility\, and sustainability?\nWith the current supply and demand imbalance in major lab markets\, how are developers and investors adjusting their strategies for life sciences companies over the next 12 to 18 months?\nAs the region’s life sciences market sees positive absorption\, especially with recent leases like BeMoreLabs\, how can developers and investors capitalize on the demand for lab space in the area amidst rising construction costs?\nGiven the shifts in policies under the Trump administration\, how do you expect changes in drug pricing strategies\, supply chain regulations and acquisition activity to impact life sciences real estate demand?\nHow can Maryland\, DC and Virginia invest in innovation programs to help enhance their role as a leader in life sciences innovation and support small businesses entering the market?\n\nWho You’ll Meet: Developers\, owners\, investors\, construction\, designers\, architects\, financial professionals and more!
URL:https://thebiocalendar.com/event/mid-atlantic-life-sciences-biotech-summit-in-maryland/
LOCATION:Bethesda\, Bethesda\, MD\, 20814\, United States
CATEGORIES:Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20251209T000000
DTEND;TZID=America/Los_Angeles:20251210T235900
DTSTAMP:20260404T065140
CREATED:20251107T152449Z
LAST-MODIFIED:20251124T142432Z
UID:9468-1765238400-1765411140@thebiocalendar.com
SUMMARY:PBM Contracting Summit
DESCRIPTION:The PBM Contracting Summit brings together industry leaders to tackle rising drug costs head-on – spotlighting bold innovations in contracting\, GLP-1 strategy\, AI-powered solutions\, and federal & state-driven regulatory change. Learn more at www.informaconnect.com/pbm-contracting-summit. Save 10% using code 25B4B10.*
URL:https://thebiocalendar.com/event/pbm-contracting-summit-3/
CATEGORIES:Summit
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2025/11/PBM_EmailHeaders.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251209
DTEND;VALUE=DATE:20251211
DTSTAMP:20260404T065140
CREATED:20250829T211343Z
LAST-MODIFIED:20251004T092508Z
UID:9066-1765238400-1765411199@thebiocalendar.com
SUMMARY:Compounding Pharmacy Compliance
DESCRIPTION:Drive Excellence in Compounding Compliance and Quality Standards \nThe Compounding Pharmacy Compliance Year-End Summit provides cutting-edge insights on GLP-1 regulatory and compliance updates\, operational excellence\, and proven strategies to drive quality\, innovation\, and long-term growth in your practice.  \nSave 10% using code 25B4B10. \n  \n 
URL:https://thebiocalendar.com/event/compounding-pharmacy-compliance-3/
LOCATION:Philadelphia\, Philadelphia\, PA\, United States
CATEGORIES:Summit,Symposium
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20251208T130000
DTEND;TZID=America/Los_Angeles:20251208T140000
DTSTAMP:20260404T065140
CREATED:20251110T123336Z
LAST-MODIFIED:20251110T123336Z
UID:9491-1765198800-1765202400@thebiocalendar.com
SUMMARY:Lessons Learned from FDA 483s and Warning Letters – Strengthening GMP Cleanroom Compliance in Life Sciences
DESCRIPTION:Cleanrooms hosting pharmaceutical manufacturing operations are inspected at a critical scale to ensure compliance to regulatory standards. With this comes a responsibility to the manufacturing operations\, quality\, facility maintenance groups and the design professional team to provide a pathway to achieve regulatory approval.  \nWe will explore critical lessons from FDA 483 observations and Warning Letters related to GMP cleanrooms in the life sciences industry. Through real-world case studies and regulatory analysis\, attendees will gain a deeper understanding of common compliance failures—ranging from inadequate contamination control to flawed cleanroom design—and how to proactively address them. Our expertise emphasizes risk-based thinking\, robust documentation practices\, and front-end design strategies to build resilient\, inspection-ready facilities.
URL:https://thebiocalendar.com/event/lessons-learned-from-fda-483s-and-warning-letters-strengthening-gmp-cleanroom-compliance-in-life-sciences/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2025/11/12-08-25-AES-eBlast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20251208T110000
DTEND;TZID=America/Los_Angeles:20251208T120000
DTSTAMP:20260404T065140
CREATED:20251106T150415Z
LAST-MODIFIED:20251106T150415Z
UID:9452-1765191600-1765195200@thebiocalendar.com
SUMMARY:Robust and Cost-Effective mRNA Capping: Critical Quality Attributes and Manufacturing Strategies
DESCRIPTION:This webinar explores the latest advancements in RNA manufacturing\, with a particular emphasis on the scalability of production processes. Special attention is given to capping strategies\, highlighting their critical role in ensuring RNA stability and translational efficiency at industrial scales. Attendees will gain insights into current challenges and innovative solutions for optimizing capping processes in large-scale RNA synthesis.
URL:https://thebiocalendar.com/event/robust-and-cost-effective-mrna-capping-critical-quality-attributes-and-manufacturing-strategies/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2025/11/12-08-25-Roche-eBlast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251208
DTEND;VALUE=DATE:20251213
DTSTAMP:20260404T065140
CREATED:20250711T172443Z
LAST-MODIFIED:20250711T172443Z
UID:8451-1765152000-1765583999@thebiocalendar.com
SUMMARY:Biotechgate Digital Partnering
DESCRIPTION:Biotechgate Digital Partnering is designed to support the business development & licensing of Pharma\, Biotech\, Medtech and Digital Health companies. Join five days of virtual partnering and establish new global connections thanks to pre-arranged one-on-one Zoom meetings in our business forum. \nRegister now to take advantage of the platform and request meetings with our global community.
URL:https://thebiocalendar.com/event/biotechgate-digital-partnering-7/
LOCATION:Online
CATEGORIES:Partnering
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251204T160000
DTEND;TZID=America/New_York:20251204T183000
DTSTAMP:20260404T065140
CREATED:20251110T212536Z
LAST-MODIFIED:20251110T212536Z
UID:9498-1764864000-1764873000@thebiocalendar.com
SUMMARY:BVS' Holiday Biotech Community Celebration at Tech Square\, Cambridge
DESCRIPTION:We are very excited to invite you to our BVS Holiday Biotech Community Event – an evening of celebration\, networking\, and festive cheer! \nMark your calendars for a great opportunity to connect with industry leaders\, explore innovative products\, and mingle with fellow professionals in the biotech community. \nThis special event is designed exclusively for all biotech tenants at 100-700 Technology Square and other biotech companies in the Cambridge area. \n✨ What to Expect: \n    Vendor Exhibit: Discover a diverse range of exhibitors showcasing cutting-edge technology and services in the biotech space.\n    Networking Opportunities: Engage with fellow industry experts\, forge new connections\, and exchange ideas that could shape the future of biotech.\n    Delicious Holiday Appetizers & Drinks: Enjoy a selection of delightful treats as you mingle. \nOur biotech community events always attract 200+ people. We are giving out holiday swag for everyone to dress up and encouraging creative holiday costumes. \nAdmission Details:\nFREE for life science job-related employees (including researchers\, scientists\, purchasing\, clinical\, manufacturing\, non-sales/bus dev positions etc.) from life science companies and research institutes.\n$200 fee for product and service providers who sell to the life science community (e.g. BVS suppliers\, business development/sales\, marketing\, lawyers\, consultants)\, which includes access to the event but does not include an exhibitor table. Exhibitor tables can be purchased separately. \nFor exhibitor tables\, please visit our website and register at: https://bvsconnection.com/events \nDon’t miss out on this fantastic opportunity to celebrate the holiday season and strengthen our biotech community. \nWe look forward to seeing you there!
URL:https://thebiocalendar.com/event/bvs-holiday-biotech-community-celebration-at-tech-square-cambridge-2/
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2025/11/BVS-Event-Flyer-12-04-25.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20251204T130000
DTEND;TZID=America/Los_Angeles:20251204T140000
DTSTAMP:20260404T065140
CREATED:20251104T142027Z
LAST-MODIFIED:20251104T142027Z
UID:9429-1764853200-1764856800@thebiocalendar.com
SUMMARY:Navigating Innovation and Challenges in Cell and Gene Therapy Bioprocessing (FREE)
DESCRIPTION:Join us for an insightful webinar featuring industry-leading experts as they explore the critical factors influencing bioprocessing in cell and gene therapies. Through a dynamic panel discussion\, we’ll delve into the most important criteria when selecting processing tools and containers\, and discuss the current state of technology that is “good enough” for today’s needs.  \nParticipants will gain valuable strategies for managing visible particles without compromising cell integrity\, and learn how autologous and allogeneic therapies impact tool selection and process consistency. The conversation will also cover future trends\, regulatory considerations for ancillary materials\, and the potential for AI to transform bioprocessing practices.
URL:https://thebiocalendar.com/event/navigating-innovation-and-challenges-in-cell-and-gene-therapy-bioprocessing-free/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20251203T110000
DTEND;TZID=America/Los_Angeles:20251203T121500
DTSTAMP:20260404T065140
CREATED:20251121T115353Z
LAST-MODIFIED:20251121T115353Z
UID:9561-1764759600-1764764100@thebiocalendar.com
SUMMARY:Message Meets Meaning: Reconnecting Science and Society
DESCRIPTION:Spotlight Panels: A New Way to Maximize Visibility for Innovative Biotech Companies \nIn a rapidly changing world\, scientific discovery has the power to transform the health and wellbeing of everyday people — yet the pace of innovation often outstrips public understanding\, policy adaptation\, and ethical reflection. This session of The Briefing Room explores how to close that gap: How can we make complex science and ideas relatable without diluting their substance? What systems and ethical frameworks can ensure that science serves society equitably and transparently? And what roles do communicators\, creatives\, and civic leaders play in building trust and meaning around science in public life? This is a conversation about responsibility\, relevance\, and the future of innovation in society. By integrating ethics\, communication\, and systems designed to connect discovery with lived experience\, this conversation aims to inspire a new paradigm: one where innovation thrives through inclusive conversation\, transparency\, and shared purpose.
URL:https://thebiocalendar.com/event/message-meets-meaning-reconnecting-science-and-society/
LOCATION:Online
CATEGORIES:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251203T100000
DTEND;TZID=America/New_York:20251203T110000
DTSTAMP:20260404T065140
CREATED:20251201T124849Z
LAST-MODIFIED:20251201T125323Z
UID:9604-1764756000-1764759600@thebiocalendar.com
SUMMARY:Quantitative 3D Whole-Brain Mapping of Sex-Specific Amyloid Pathology in the APP-PS1 (ARTE10) Mouse Model
DESCRIPTION:Alzheimer’s disease is the most common cause of dementia. It is associated with the build-up of small protein aggregates in the brain\, termed β-amyloid plaques\, ultimately leading to brain damage and memory loss. Overall\, more women are affected by Alzheimer’s disease than men\, but the reasons for these differences are not fully understood. Elucidating these differences is crucial for improving therapies aimed at reducing the detrimental impact of β-amyloid plaque buildup. \nThis study aimed to investigate sex-specific β-amyloid plaque dynamics in a female and male transgenic mouse model of Alzheimer’s disease. To enable this\, we employed 3-dimensional imaging to map and quantify β-amyloid plaques throughout the intact mouse brain at different ages. We found that female transgenic mice develop β-amyloid plaques earlier and show a more rapid and widespread accumulation than their male counterparts in almost all parts of the brain. \nIn conclusion\, our study provides the first quantitative assessment of sex differences in progressive β-amyloid plaque pathology across the entire brain in a mouse model of Alzheimer’s disease\, offering insights that may guide future research and inform the development of sex-specific treatment strategies.
URL:https://thebiocalendar.com/event/quantitative-3d-whole-brain-mapping-of-sex-specific-amyloid-pathology-in-the-app-ps1-arte10-mouse-model/
LOCATION:Online webinar\, United States
CATEGORIES:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20251202T110000
DTEND;TZID=America/Los_Angeles:20251202T120000
DTSTAMP:20260404T065140
CREATED:20251106T150004Z
LAST-MODIFIED:20251106T150004Z
UID:9444-1764673200-1764676800@thebiocalendar.com
SUMMARY:Streamline the Critical Path for Gene Therapy: Key Considerations for the AAV Analytical Lifecycle
DESCRIPTION:AAV vectors offer clear benefits for gene therapy\, and continued advances in technology have increased target specificity\, improved potency\, and intensified production efficiency.  Even with significant attention early in development\, analytical activities for gene therapy often land on the critical path.   \nThis webinar provides considerations for phase-appropriate AAV characterization and release activities from pre-clinical to late-phase products. Early-stage analytical topics will address how to leverage platform analytics\, client-specific methods and transfers\, formulation verifications\, tox material testing\, and stability. Late-stage focus will review continued development activities\, timing of method validation\, IPC verifications\, and data trending. We will discuss potential challenges in validation of late-stage analytics for PPQ and late-phase testing and paths for maturation of platform and product-specific analytics.
URL:https://thebiocalendar.com/event/streamline-the-critical-path-for-gene-therapy-key-considerations-for-the-aav-analytical-lifecycle/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2025/11/12-02-25-Catalent-eBlast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20251202T080000
DTEND;TZID=America/Los_Angeles:20251202T120000
DTSTAMP:20260404T065140
CREATED:20251125T142457Z
LAST-MODIFIED:20251125T142457Z
UID:9581-1764662400-1764676800@thebiocalendar.com
SUMMARY:2025 Boston Biotech Summit
DESCRIPTION:What You’ll Learn: \n\nHow will lower interest rates influence biotech funding\, investment flows\, and real estate capital allocation in 2025?\nWith a record volume of new lab and GMP supply delivering this year\, how can owners make their assets stand out in a crowded market?\nIs renewed activity in biotech IPOs and venture funding a sign of sustained momentum heading into 2026?\nHow is Boston’s biotech ecosystem continuing to foster innovation\, and what distinctive advantages will support its rebound?\nWhat impact have major development projects across Greater Boston had on advancing the region’s life sciences growth and competitiveness?\nAs vacancy climbs above 30% in Greater Boston\, is the balance of power shifting further toward tenants\, and what will they expect from new space?\nHow is technology driving the demand for flexible\, adaptable labs and GMP facilities that can evolve with science?\nIn what ways has tenant demand for modular layouts\, spec suites\, and shorter lease terms reshaped leasing dynamics in 2025?\nWhy is biomanufacturing becoming a stabilizing force for the market\, and how are GMP facilities attracting both tenants and investors?\n\nHow you’ll do more business: \nConnect with industry leaders to explore emerging leasing dynamics\, gain valuable investor insights and discover cutting-edge innovations in workspace design. Gain insights into the trade-offs and advantages associated with advanced manufacturing techniques and Good Manufacturing Practice\, or GMP\, standards in biotech. Explore topics like sustainable facility design\, power solutions\, access considerations and other crucial aspects that can enhance your business strategy.  \nWho attends: \nInvestors\, owners\, developers\, tenants\, end users\, brokers\, lawyers\, designers\, contractors\, architects\, property managers and more!
URL:https://thebiocalendar.com/event/2025-boston-biotech-summit/
LOCATION:Somerville\, Somerville\, MA\, United States
CATEGORIES:Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20251202T080000
DTEND;TZID=America/Los_Angeles:20251202T113000
DTSTAMP:20260404T065140
CREATED:20251125T142613Z
LAST-MODIFIED:20251125T142613Z
UID:9582-1764662400-1764675000@thebiocalendar.com
SUMMARY:Philadelphia Life Sciences Conference
DESCRIPTION:Greater Philadelphia sits at the forefront of a dynamic life sciences evolution\, where strategic decision-making today will shape the trajectory of the region’s biotech and innovation economy for years to come. As funding landscapes shift\, groundbreaking research emerges\, and tenant demands evolve\, stakeholders across commercial real estate\, including developers\, investors\, and brokers\, need critical insights to navigate the complex marketplace. \nPhiladelphia boasts robust research institutions\, cutting-edge talent\, and a collaborative ecosystem uniquely positioned to nurture startups into thriving enterprises. But retaining these innovative companies locally demands strategic investment and thoughtfully designed infrastructure. This event provides essential guidance on fostering a robust “bench-to-market” pipeline\, securing creative financing amid challenging market conditions\, and capitalizing on opportunities poised to reshape the region. \nJoin industry leaders\, innovators\, and policymakers as they delve deep into strategies for attracting and retaining tenants\, leveraging financial tools\, and building the resilient and adaptive infrastructure needed for Philadelphia’s sustained growth in life sciences real estate. \nWhat You Will Learn: \n\nPhiladelphia’s “Secret Sauce” for Startups: The city offers a unique blend of assets for life science entrepreneurs – world-class research institutions producing cutting-edge IP and talent\, plus a culture of collaboration where academia\, industry\, and government actively work together. Hear how this has created fertile ground for startups. For instance\, the University City Science Center’s expansion with Wexford and Ventas now spans 11 city blocks and houses 200+ companies\, providing critical lab space and networking for entrepreneurs. We’ll hear success stories of companies that started in a campus lab or incubator and grew into standalone firms\, illustrating the “incubation-to-graduation” pipeline now established in Philly .\nRetaining Homegrown Companies: What does it takes to keep companies in the region through their growth stages. Philadelphia’s “bench-to-market” pathway is increasingly robust\, a company can start at a university lab\, launch at a BioLabs or B+Labs incubator\, then move up to a larger space in the city\, and even establish manufacturing at sites like the Navy Yard\, all without leaving Greater Philadelphia . This continuum (rare among cities) is a selling point. Hear how to leverage initiatives and how to address any gaps so that Philly’s brightest biotech companies scale up locally rather than relocate.\nCapital Markets and Development Strategy: Higher interest rates and cautious lenders have forced developers to be more strategic\, often requiring pre-leases for new projects. Experts will share how they are securing financing\, using creative tools (C-PACE\, JV partnerships) and timing projects to ride out the storm .\nPhiladelphia’s Competitive Edge: Highlight fundamentals keeping Philly on top – huge research institutions and NIH funding\, a rise in lab rents in University City\, and abundant STEM talent. These factors\, plus a cost advantage\, position the region to rebound strongly as confidence returns.\nDeveloper Financing Strategies in a Tight Market: With traditional debt financing more expensive\, developers have had to get creative to fund projects. Panelists will share firsthand experiences structuring deals\, (including C-PACE and regional bank loans) amid a tough lending environment. Examine how life science projects can leverage public sector support and how some developers are deferring or phasing projects to align with capital availability.\nOpportunities on the Horizon: Despite the current caution\, Philadelphia’s fundamentals continue to attract interest. Are developers quietly assembling capital to pounce on distressed lab assets or conversions at a discount? Will the suburban markets (with their lower costs and existing pharma infrastructure) see a faster revival? And how can public initiatives be leveraged to catalyze public-private investment in new research facilities or workforce training centers?
URL:https://thebiocalendar.com/event/philadelphia-life-sciences-conference/
LOCATION:Philadelphia\, Philadelphia\, PA\, United States
CATEGORIES:Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20251201T110000
DTEND;TZID=America/Los_Angeles:20251201T120000
DTSTAMP:20260404T065140
CREATED:20251104T142351Z
LAST-MODIFIED:20251104T142351Z
UID:9433-1764586800-1764590400@thebiocalendar.com
SUMMARY:The Science of CRO Selection: Insights from $2B+ in Vendor Selections
DESCRIPTION:Selecting the right CRO is one of the most critical decisions in clinical development\, yet rarely a straightforward one. Sponsors often find that comparing CRO proposals isn’t an apples-to-apples exercise — with variations in assumptions\, timelines\, and resource structures making true comparisons difficult. \nThis session draws on insights from more than $2B in CRO selections facilitated through the Clin.AI platform\, showing how sponsors can bring structure and transparency to the process. We’ll discuss how the RFP should serve not just as a budget exercise\, but as a strategic opportunity to evaluate timelines\, resources\, and operational readiness — while engaging internal stakeholders and aligning expectations early. \nUltimately\, the goal is to help sponsors identify the right cultural and operational fit — a partner who can execute efficiently\, manage risk\, and deliver on time and within budget.
URL:https://thebiocalendar.com/event/the-science-of-cro-selection-insights-from-2b-in-vendor-selections/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2025/11/12-01-25-ClinAI-eBlast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20251121T180000
DTEND;TZID=America/Los_Angeles:20251121T210000
DTSTAMP:20260404T065140
CREATED:20251121T193142Z
LAST-MODIFIED:20251121T193142Z
UID:9565-1763748000-1763758800@thebiocalendar.com
SUMMARY:STAT@JPM: Health Care at a Crossroads
DESCRIPTION:Never has so much been at stake when it comes to investments in health care. All kinds of uncertainty — political\, social\, and scientific — stand between new preventatives\, treatments\, and cures and the patients who need them. But never has investment been more important either. Join us for a look at what is at stake\, what is ahead\, and ideas for developing new medicines in 2026. \nFeatured Speakers \n\nYvonne Greenstreet\, M.D.\, MBA\, OBE\, chief executive officer\, Alnylam Pharmaceuticals\nAgustin Mohedas\, Ph.D.\, portfolio manager\, research analyst\, Janus Henderson Investments\nRoderick Wong\, M.D.\, managing partner\, chief investment officer\, RTW\nTeresa Graham\, chief executive officer\, Roche Pharmaceuticals (sponsor speaker)
URL:https://thebiocalendar.com/event/statjpm-health-care-at-a-crossroads/
LOCATION:San Francisco\, CA\, San Francisco\, CA\, United States
CATEGORIES:Forum
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251120T160000
DTEND;TZID=America/New_York:20251120T190000
DTSTAMP:20260404T065140
CREATED:20251023T171726Z
LAST-MODIFIED:20251110T180918Z
UID:9407-1763654400-1763665200@thebiocalendar.com
SUMMARY:BVS’ Biotech Innovation & Vendor Expo at the Cambridge Marriott
DESCRIPTION:We are very excited to announce our indoor Biotech Innovation & Vendor Expo at the Cambridge Marriott. \nMark your calendars for a great opportunity to connect with industry leaders\, explore innovative products\, and mingle with fellow professionals in the biotech community. \nThis biotech community event will bring together researchers from local biotech/pharma accounts in Cambridge/Boston and the surrounding areas to see the latest in tools\, technologies\, and equipment to help advance life science research. \n✨ What to Expect: \n    Vendor Exhibits: Discover a diverse range of exhibitors showcasing cutting-edge technology and services in the biotech space.\n    Networking Opportunities: Engage with fellow industry experts\, forge new connections\, and exchange ideas that could shape the future of biotech.\n    Delicious Food and Drinks: Enjoy delicious food and drinks s as you network and explore the vendor exhibits. \nAdmission Details:\nFREE for life science job-related employees (including researchers\, scientists\, purchasing\, clinical\, manufacturing\, etc.) from life science companies and research institutes.\n$250 fee for product and service providers who sell to the life science community (e.g. BVS suppliers\, business development/sales\, marketing\, lawyers\, consultants)\, which includes access to the event but does not include an exhibitor table. Exhibitor tables can be purchased separately. \nFor exhibitor tables\, please visit our website and register at: https://bvsconnection.com/events \nPlease feel free to invite others in the community that could benefit from attending. \nWe look forward to seeing you there!
URL:https://thebiocalendar.com/event/bvs-innovation-symposium-vendor-expo-in-cambridge/
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2025/10/SYMPOSIUM-Vendor-flyer-11-20-25.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251120T110000
DTEND;TZID=America/New_York:20251120T120000
DTSTAMP:20260404T065140
CREATED:20251016T171710Z
LAST-MODIFIED:20251023T131111Z
UID:9274-1763636400-1763640000@thebiocalendar.com
SUMMARY:Unpacking pDNA processes: Capacity\, complexity\, and cutting-edge solutions (FREE WEBINAR)
DESCRIPTION:As the demand for plasmid DNA (pDNA) continues to surge across gene therapies\, mRNA vaccines\, and cell therapies\, manufacturers are facing growing pressure to expand capacity with speed and precision. But scaling pDNA production is far from straightforward. Unforeseen complexities in areas like facility design or process innovation often leads to costly delays and missed opportunities. \nIn this expert-led panel discussion\, industry leaders from Cytiva\, Bionova\, and other innovators will unpack the evolving landscape of pDNA manufacturing. You’ll gain insights into key trends driving therapeutic demand\, common missteps in capacity planning\, and how modular\, flexible facility design can accelerate GMP readiness. The panel will also spotlight exciting process innovations in fermentation\, purification\, and analytics—plus offer candid perspectives on the biggest challenges and opportunities shaping the future of the pDNA industry. \nWhether you’re entering the pDNA space or preparing for scale up\, this session will offer actionable strategies to help you navigate the road ahead.
URL:https://thebiocalendar.com/event/unpacking-pdna-processes-capacity-complexity-and-cutting-edge-solutions-free-webinar/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2025/10/Untitled-design-43.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20251120T080000
DTEND;TZID=America/Los_Angeles:20251121T170000
DTSTAMP:20260404T065140
CREATED:20250902T214542Z
LAST-MODIFIED:20250902T214542Z
UID:9158-1763625600-1763744400@thebiocalendar.com
SUMMARY:Patient Support Services Congress
DESCRIPTION:This congress is designed to help educate and share innovative program design\, latest customer strategies and practical solutions to overcome complex barriers\, enhance program performance and deliver best-in-class patient programs amidst evolving regulations. Compliance and Operations teams unite at Patient Support Services Congress for next-level benchmarking to drive program success. Benefit from collaborative sessions as well as individualized tracked content and walk away with everything you need to propel your program forward. \n \n 
URL:https://thebiocalendar.com/event/patient-support-services-congress-3/
LOCATION:East Brunswick\, NJ
CATEGORIES:Summit
END:VEVENT
END:VCALENDAR